ATE227146T1 - Verbesserter transdermaler transport unter verwendung von ultraschall - Google Patents

Verbesserter transdermaler transport unter verwendung von ultraschall

Info

Publication number
ATE227146T1
ATE227146T1 AT96925491T AT96925491T ATE227146T1 AT E227146 T1 ATE227146 T1 AT E227146T1 AT 96925491 T AT96925491 T AT 96925491T AT 96925491 T AT96925491 T AT 96925491T AT E227146 T1 ATE227146 T1 AT E227146T1
Authority
AT
Austria
Prior art keywords
ultrasound
drugs
transdermal transport
analytes
microparticles
Prior art date
Application number
AT96925491T
Other languages
English (en)
Inventor
Samir S Mitragotri
Uwe Pliquett
Mark E Johnson
Michael Pishko
Joseph Kost
Robert S Langer
James C Weaver
Daniel Blankschtein
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/507,060 external-priority patent/US6002961A/en
Priority claimed from US08/511,583 external-priority patent/US5814599A/en
Priority claimed from US08/574,377 external-priority patent/US5947921A/en
Priority claimed from US08/626,021 external-priority patent/US6041253A/en
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of ATE227146T1 publication Critical patent/ATE227146T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
    • A61B5/1451—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
    • A61B5/14514—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid using means for aiding extraction of interstitial fluid, e.g. microneedles or suction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0047—Sonopheresis, i.e. ultrasonically-enhanced transdermal delivery, electroporation of a pharmacologically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0092—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/327—Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
AT96925491T 1995-07-25 1996-07-25 Verbesserter transdermaler transport unter verwendung von ultraschall ATE227146T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/507,060 US6002961A (en) 1995-07-25 1995-07-25 Transdermal protein delivery using low-frequency sonophoresis
US08/511,583 US5814599A (en) 1995-08-04 1995-08-04 Transdermal delivery of encapsulated drugs
US08/574,377 US5947921A (en) 1995-12-18 1995-12-18 Chemical and physical enhancers and ultrasound for transdermal drug delivery
US08/626,021 US6041253A (en) 1995-12-18 1996-04-01 Effect of electric field and ultrasound for transdermal drug delivery
PCT/US1996/012244 WO1997004832A1 (en) 1995-07-25 1996-07-25 Enhanced transdermal transport using ultrasound

Publications (1)

Publication Number Publication Date
ATE227146T1 true ATE227146T1 (de) 2002-11-15

Family

ID=27504462

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96925491T ATE227146T1 (de) 1995-07-25 1996-07-25 Verbesserter transdermaler transport unter verwendung von ultraschall

Country Status (7)

Country Link
EP (1) EP0781150B1 (de)
JP (1) JPH10509632A (de)
AT (1) ATE227146T1 (de)
AU (1) AU725269B2 (de)
CA (1) CA2200984A1 (de)
DE (1) DE69624668T2 (de)
WO (1) WO1997004832A1 (de)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885211A (en) * 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
TR199800347T1 (xx) * 1995-08-29 1998-05-21 Spectrx, Inc. �la� uygulamas� i�in insan derisinin mikro-g�zeneklendirilmesi ve uygulamalar�n g�zlemlenmesi.
US6234990B1 (en) 1996-06-28 2001-05-22 Sontra Medical, Inc. Ultrasound enhancement of transdermal transport
US20060002949A1 (en) 1996-11-14 2006-01-05 Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. Transcutaneous immunization without heterologous adjuvant
US6527716B1 (en) 1997-12-30 2003-03-04 Altea Technologies, Inc. Microporation of tissue for delivery of bioactive agents
WO1998029134A2 (en) * 1996-12-31 1998-07-09 Altea Technologies, Inc. Microporation of tissue for delivery of bioactive agents
DE29705633U1 (de) * 1997-04-01 1997-05-22 Zimmermann Johann Dipl Ing Elektro-Magnet-Pen
DE69941447D1 (de) 1998-01-05 2009-11-05 Univ Washington Erhöhter transport unter benutzung membranzerstörender stoffe
WO1999034857A1 (en) 1998-01-08 1999-07-15 Sontra Medical, Inc. Sonophoretic enhanced transdermal transport
WO2000035357A1 (en) * 1998-12-18 2000-06-22 Sontra Medical, Inc. Methods and apparatus for enhancement of transdermal transport
US6173202B1 (en) 1998-03-06 2001-01-09 Spectrx, Inc. Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue
US6587705B1 (en) 1998-03-13 2003-07-01 Lynn Kim Biosensor, iontophoretic sampling system, and methods of use thereof
US6322532B1 (en) 1998-06-24 2001-11-27 3M Innovative Properties Company Sonophoresis method and apparatus
US7384396B2 (en) 1998-07-21 2008-06-10 Spectrx Inc. System and method for continuous analyte monitoring
US7037277B1 (en) 1998-07-21 2006-05-02 Spectrx, Inc. System and method for fluid management in a continuous fluid collection and sensor device
US6192270B1 (en) * 1998-08-14 2001-02-20 Genetronics, Inc. Apparatus and method for the delivery of drugs and genes into tissue
US7229621B2 (en) * 1998-10-20 2007-06-12 Torrey Pines Institute For Molecular Studies Method to enhance the immunogenicity of an antigen
DE19850517B4 (de) * 1998-11-03 2004-02-12 Lts Lohmann Therapie-Systeme Ag Verwendung eines wirkstoffhaltigen transdermalen therapeutischen Systems in einer Kombinationsbehandlung mit und ohne Ultraschall
US6475514B1 (en) 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
US20040171980A1 (en) 1998-12-18 2004-09-02 Sontra Medical, Inc. Method and apparatus for enhancement of transdermal transport
CA2376368C (en) * 1999-06-08 2009-08-11 Altea Technologies, Inc. Apparatus for microporation of biological membranes using thin film tissue interface devices, and method therefor
US20040039342A1 (en) 2000-06-08 2004-02-26 Jonathan Eppstein Transdermal integrated actuator device, methods of making and using same
AU6076200A (en) 1999-07-08 2001-01-30 Johnson & Johnson Consumer Companies, Inc. Exothermic bandage
US6890553B1 (en) 1999-07-08 2005-05-10 Johnson & Johnson Consumer Companies, Inc. Exothermic topical delivery device
US20030078499A1 (en) 1999-08-12 2003-04-24 Eppstein Jonathan A. Microporation of tissue for delivery of bioactive agents
US7133717B2 (en) 1999-08-25 2006-11-07 Johnson & Johnson Consumer Companies, Inc. Tissue electroperforation for enhanced drug delivery and diagnostic sampling
US7113821B1 (en) 1999-08-25 2006-09-26 Johnson & Johnson Consumer Companies, Inc. Tissue electroperforation for enhanced drug delivery
US7737108B1 (en) 2000-01-07 2010-06-15 University Of Washington Enhanced transport using membrane disruptive agents
JP2003527613A (ja) * 2000-03-17 2003-09-16 ソントラ・メディカル・インコーポレーテッド 体液の非侵襲性のサンプリングおよび分析のためのシステム、方法およびデバイス
US7404815B2 (en) 2000-05-01 2008-07-29 Lifescan, Inc. Tissue ablation by shear force for sampling biological fluids and delivering active agents
US7597692B2 (en) 2000-06-08 2009-10-06 Massachusetts Institute Of Technology Microscission processes and procedures
US6706032B2 (en) 2000-06-08 2004-03-16 Massachusetts Institute Of Technology Localized molecular and ionic transport to and from tissues
US6790179B2 (en) 2001-08-01 2004-09-14 Johnson & Johnson Consumer Companies, Inc. Method of examining and diagnosing skin health
US6855117B2 (en) 2001-08-01 2005-02-15 Johnson & Johnson Consumer Companies, Inc. Method of treating the skin of a subject
US6840910B2 (en) 2001-08-01 2005-01-11 Johnson & Johnson Consumer Companies, Inc. Method of distributing skin care products
US7135029B2 (en) 2001-06-29 2006-11-14 Makin Inder Raj S Ultrasonic surgical instrument for intracorporeal sonodynamic therapy
TWI220386B (en) 2002-01-21 2004-08-21 Matsushita Electric Works Ltd Ultrasonic transdermal permeation device
JP2005530695A (ja) * 2002-02-15 2005-10-13 ザイコス インク． 生理活性物質を細胞内に導入するエレクトロポレーション法
US9918665B2 (en) 2002-03-11 2018-03-20 Nitto Denko Corporation Transdermal porator and patch system and method for using same
US20040009180A1 (en) * 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
AU2006252145B2 (en) * 2002-08-23 2009-05-07 Sheiman Ultrasonic Research Foundation Pty Ltd Synergetic drug delivery device
WO2004073794A2 (en) * 2003-02-19 2004-09-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Device, methods and sponges for iontophoretic drug delivery
CN100588436C (zh) 2003-06-13 2010-02-10 宝洁公司 透皮吸收超声波护肤装置
US8016811B2 (en) 2003-10-24 2011-09-13 Altea Therapeutics Corporation Method for transdermal delivery of permeant substances
WO2007028981A1 (en) * 2005-09-08 2007-03-15 University Of Dundee Apparatus and method for sonoporation
GB0518273D0 (en) * 2005-09-08 2005-10-19 Univ Dundee Apparatus and method for sonoporation
JP2009539508A (ja) * 2006-06-15 2009-11-19 シーガル アイピー ピーティーワイ リミテッド 送達システム及び方法
US8192474B2 (en) 2006-09-26 2012-06-05 Zeltiq Aesthetics, Inc. Tissue treatment methods
US9132031B2 (en) 2006-09-26 2015-09-15 Zeltiq Aesthetics, Inc. Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile
DE102006047274A1 (de) 2006-10-04 2008-04-10 Michaela Braun Vorrichtung zur Elektroporation und deren Verwendung
EP2152358B1 (de) 2007-04-27 2011-03-02 Echo Therapeutics, Inc. Hautpermeationsvorrichtung für Analytenmessung oder transdermale Arzneiabgabe
EP2152351B1 (de) * 2007-05-07 2016-09-21 Guided Therapy Systems, L.L.C. Verfahren und systeme zur modulierung von medikamenten mit akustischer energie
US20080287839A1 (en) 2007-05-18 2008-11-20 Juniper Medical, Inc. Method of enhanced removal of heat from subcutaneous lipid-rich cells and treatment apparatus having an actuator
US8523927B2 (en) 2007-07-13 2013-09-03 Zeltiq Aesthetics, Inc. System for treating lipid-rich regions
JP5474791B2 (ja) 2007-08-21 2014-04-16 ゼルティック エステティックス インコーポレイテッド 脂肪組織の冷却のような皮下脂質リッチ細胞の冷却の監視
US20110020429A1 (en) * 2007-12-10 2011-01-27 Epitarget As Use of particles comprising an alcohol
US8545440B2 (en) 2007-12-21 2013-10-01 Carticept Medical, Inc. Injection system for delivering multiple fluids within the anatomy
US8002736B2 (en) 2007-12-21 2011-08-23 Carticept Medical, Inc. Injection systems for delivery of fluids to joints
US9044542B2 (en) 2007-12-21 2015-06-02 Carticept Medical, Inc. Imaging-guided anesthesia injection systems and methods
US8603073B2 (en) 2008-12-17 2013-12-10 Zeltiq Aesthetics, Inc. Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells
AU2010242785B2 (en) 2009-04-30 2014-03-06 Zeltiq Aesthetics, Inc. Device, system and method of removing heat from subcutaneous lipid-rich cells
JP2013517897A (ja) 2010-01-25 2013-05-20 ゼルティック エステティックス インコーポレイテッド 熱を皮下多脂質細胞から相変化冷却剤を介して非侵襲的に除去するための家庭用アプリケータ及びそれと関連した装置、システム及び方法
US8676338B2 (en) 2010-07-20 2014-03-18 Zeltiq Aesthetics, Inc. Combined modality treatment systems, methods and apparatus for body contouring applications
WO2012103242A1 (en) 2011-01-25 2012-08-02 Zeltiq Aesthetics, Inc. Devices, application systems and methods with localized heat flux zones for removing heat from subcutaneous lipid-rich cells
AU2013277943B2 (en) * 2012-06-22 2018-07-05 Unisa Ventures Pty Ltd Method and composition for delivering a compound through a biological barrier
US9545523B2 (en) 2013-03-14 2017-01-17 Zeltiq Aesthetics, Inc. Multi-modality treatment systems, methods and apparatus for altering subcutaneous lipid-rich tissue
US9844460B2 (en) 2013-03-14 2017-12-19 Zeltiq Aesthetics, Inc. Treatment systems with fluid mixing systems and fluid-cooled applicators and methods of using the same
WO2015117026A2 (en) 2014-01-31 2015-08-06 Zeltiq Aesthetics, Inc. Treating systems and methods for treating cellulite and providing other treatments
US10675176B1 (en) 2014-03-19 2020-06-09 Zeltiq Aesthetics, Inc. Treatment systems, devices, and methods for cooling targeted tissue
USD777338S1 (en) 2014-03-20 2017-01-24 Zeltiq Aesthetics, Inc. Cryotherapy applicator for cooling tissue
US10952891B1 (en) 2014-05-13 2021-03-23 Zeltiq Aesthetics, Inc. Treatment systems with adjustable gap applicators and methods for cooling tissue
US10935174B2 (en) 2014-08-19 2021-03-02 Zeltiq Aesthetics, Inc. Stress relief couplings for cryotherapy apparatuses
US10568759B2 (en) 2014-08-19 2020-02-25 Zeltiq Aesthetics, Inc. Treatment systems, small volume applicators, and methods for treating submental tissue
US9459201B2 (en) 2014-09-29 2016-10-04 Zyomed Corp. Systems and methods for noninvasive blood glucose and other analyte detection and measurement using collision computing
WO2017070112A1 (en) 2015-10-19 2017-04-27 Zeltiq Aesthetics, Inc. Vascular treatment systems, cooling devices, and methods for cooling vascular structures
CN108472151B (zh) 2016-01-07 2020-10-27 斯尔替克美学股份有限公司 在组织冷却期间施用器与皮肤之间的温度依赖性粘附
US10765552B2 (en) 2016-02-18 2020-09-08 Zeltiq Aesthetics, Inc. Cooling cup applicators with contoured heads and liner assemblies
US9554738B1 (en) 2016-03-30 2017-01-31 Zyomed Corp. Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing
US11382790B2 (en) 2016-05-10 2022-07-12 Zeltiq Aesthetics, Inc. Skin freezing systems for treating acne and skin conditions
US10682297B2 (en) 2016-05-10 2020-06-16 Zeltiq Aesthetics, Inc. Liposomes, emulsions, and methods for cryotherapy
US10555831B2 (en) 2016-05-10 2020-02-11 Zeltiq Aesthetics, Inc. Hydrogel substances and methods of cryotherapy
KR101840424B1 (ko) * 2016-09-12 2018-03-20 주식회사 퍼시픽시스템 미세 입자를 보관하는 보관 박막 및 보관 박스
US11076879B2 (en) 2017-04-26 2021-08-03 Zeltiq Aesthetics, Inc. Shallow surface cryotherapy applicators and related technology
US11446175B2 (en) 2018-07-31 2022-09-20 Zeltiq Aesthetics, Inc. Methods, devices, and systems for improving skin characteristics

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948587A (en) * 1986-07-08 1990-08-14 Massachusetts Institute Of Technology Ultrasound enhancement of transbuccal drug delivery
US4767402A (en) * 1986-07-08 1988-08-30 Massachusetts Institute Of Technology Ultrasound enhancement of transdermal drug delivery
US5008110A (en) * 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5115805A (en) * 1990-02-23 1992-05-26 Cygnus Therapeutic Systems Ultrasound-enhanced delivery of materials into and through the skin
US5421816A (en) * 1992-10-14 1995-06-06 Endodermic Medical Technologies Company Ultrasonic transdermal drug delivery system
US5386837A (en) * 1993-02-01 1995-02-07 Mmtc, Inc. Method for enhancing delivery of chemotherapy employing high-frequency force fields
CA2114968A1 (en) * 1993-02-25 1994-08-26 John Wille Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
US5415629A (en) * 1993-09-15 1995-05-16 Henley; Julian L. Programmable apparatus for the transdermal delivery of drugs and method
US5445611A (en) * 1993-12-08 1995-08-29 Non-Invasive Monitoring Company (Nimco) Enhancement of transdermal delivery with ultrasound and chemical enhancers

Also Published As

Publication number Publication date
CA2200984A1 (en) 1997-02-13
EP0781150B1 (de) 2002-11-06
EP0781150A1 (de) 1997-07-02
DE69624668D1 (de) 2002-12-12
JPH10509632A (ja) 1998-09-22
AU6598796A (en) 1997-02-26
AU725269B2 (en) 2000-10-12
WO1997004832A1 (en) 1997-02-13
DE69624668T2 (de) 2003-08-28

Similar Documents

Publication Publication Date Title
ATE227146T1 (de) Verbesserter transdermaler transport unter verwendung von ultraschall
WO1997004832B1 (en) Enhanced transdermal transport using ultrasound
DE3789035D1 (de) Vorrichtung zur transdermalen Applikation von wirksamen Substanzen.
CA2317777A1 (en) Sonophoretic enhanced transdermal transport
DE69728525D1 (de) Mittels vakuum verbesserter transdermaler flüssigkeitstransport
DE69532282D1 (de) Vorrichtung zur probenentnahme mittels polaritätsumkehrung
DE69230890T2 (de) Bestimmung von nukleären matrixproteinen in flüssigkeiten
DE69119231D1 (de) Verfahren und vorrichtung zur bestimmung von chemischen spezies in körperflüssigkeit
DE60018796D1 (de) Vorrichtung zur erhöhung des transdermalen flusses von probenwirkstoffen
DE68924779D1 (de) Vorrichtung und verfahren zum nachweis von chemischen spezies.
DE69033983T2 (de) Verwendung von funktionellen Derivaten des Interzellulär-Adhäsions-Moleküls ICAM-1 in einer Antivirus-Therapie
ATE111426T1 (de) Verfahren und vorrichtung zum elektroaktivieren von fluiden.
Berg et al. Electrostimulation in cell biology by low-frequency electromagnetic fields
Tang et al. Electrochemical studies of the intercalation of ethidium bromide to DNA
DE69412355T2 (de) Kombinierte Anwendung von Chemikalien und Mikroorganismen in der Bekämpfung von Schaben
Belyaev et al. Cooperativity in E. coli cell response to resonance effect of weak extremely low frequency electromagnetic field
Tsong Na, K-ATPase as a Brownian motor: Electric field-inducedconformational fluctuation leads to uphill pumping of cation inthe absence of ATP
WO2001028500A3 (en) Uses of antileukoprotease in carcinoma
Sontag Release of mediators by DMSO-differentiated HL-60 cells exposed to electric interferential current and the requirement of biochemical prestimulation
RU94020306A (ru) Способ получения активной воды
JPH0626287Y2 (ja) 磁気治療貼り薬の貼付器具
RU94045239A (ru) Способ определения начальной магнитной восприимчивости магнитных жидкостей
FR2322615A1 (fr) Procede d'application cutanee en vue d'une penetration sous-cutanee de divers produits et produit pour sa mise en oeuvre
Clark The biosensor: electronics meets biology
Finger et al. Quantal stores of excitatory transmitter in nerve-muscle synapses of crayfish evaluated from high-frequency asynchronous quantal release induced by veratridine or high concentrations of potassium

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties